LEAD Coalition Supports Passage of the CHANGE Act

On June 20, 147 LEAD Coalition member organizations and allies wrote to Congress in support of the Concentrating on High-Value Alzheimer’s Needs to Get to an End (CHANGE) Act (S. 2387/H.R.4957). The legislation encourages early assessment and diagnosis, seeks to reduce caregiver burden and helps accelerate progress to develop disease modifying treatments. Read the letters […]

LEAD Coalition urges Congress to boost FY 2019 funding for dementia care, support and science

On April 24, 152 LEAD Coalition member organizations and allies wrote to Congress urging that the FY 2019 appropriations bills include substantial increases in funding to strengthen the national response to Alzheimer’s disease and related forms of dementia.  Read the Senate and House letters.

LEAD Coalition Supports Passage of the BOLD Infrastructure for Alzheimer’s Act

On March 6, 151 LEAD Coalition member organizations and allies wrote to congressional sponsors in support of the Building Our Largest Dementia (BOLD) Infrastructure for Alzheimer’s Act (S. 2076/H.R.4256). The legislation would create infrastructure across the country to implement effective dementia interventions focused on public health issues such as increasing early detection and diagnosis, reducing risk and […]

Accelerating Cognitive Impairment Assessment and Advanced Diagnostics

By Edward I. Ginns, MD, Ph.D., DABCC It’s been one year since Medicare began reimbursing primary care physicians for assessments of cognitive impairment disorders and provision of care-coordination services. Given that research shows providers are not identifying cognitive impairment in up to 50 percent of their cognitively impaired patients — and that about 30 percent […]